See how Tirosint-SOL helped
Aza Muñoz get back in full
swing – on and off the course.

Aza Muñoz, professional golfer (sponsored by Tirosint-SOL),
has Hashimoto’s Thyroiditis.

“I’m so grateful I discovered Tirosint-SOL. It’s been a game changer. I’m energetic from the time I wake up, and I don’t feel achy anymore. I almost forgot how that felt.” -Aza Muñoz

Aza Muñoz porfessional golfer

Professional golfer Aza Muñoz has been a natural on the course since she started playing with her friends as a child in Spain. A few years ago, however, she found herself feeling tired all the time, was constantly cold and achy, started losing hair, and didn’t have the motivation she used to. At first Aza thought that her symptoms were from stress from the demands of being on tour, but after months of no improvement, she went to see her doctor about it.

Aza was diagnosed with Hashimoto’s Thyroiditis, an autoimmune disease that can cause hypothyroidism. She tried to treat her symptoms using conventional thyroid hormone tablets, but even with medication, she didn’t feel right. She struggled to put the amount of energy into practice that she needed to keep her game at a high level. After consulting with her doctor, she decided to take a different course and try Tirosint-SOL (levothyroxine sodium) oral solution to treat her hypothyroidism.

Thankfully, Aza’s hypothyroid symptoms are now under control, and she’s back in full swing – both on and off the golf course.

If you suffer from hypothyroidism, or are struggling to find the right medication or dose, talk to your doctor today to find out if Tirosint-SOL is right for you.

Tirosint-SOL is a unique levothyroxine formulation that contains only 3 ingredients:

Tirosint-SOL card

Use the Tirosint-SOL Copay Savings Card to reduce the out-of-pocket cost of your prescription

Tirosint-SOL baloon

Learn more about the Tirosint Direct Program to pay the lowest out-of-pocket cash price for your prescribed therapy

Taking Tirosint-SOL is as easy as drinking water

You can take Tirosint-SOL oral solution by pouring it into a glass of water and drinking it. It also can be administered by squeezing the contents of the ampule directly into your mouth.

Note: Do not mix Tirosint-SOL with any other liquid but water.

Are you a healthcare provider? IBSA Pharma is committed to supporting healthcare professionals in their mission to treat patients. Learn more about a variety of Tirosint-SOL patient support materials available for your practice, and request product samples to share with your patients.

Doctor and patient

Tirosint-SOL Important Safety Information



IMPORTANT SAFETY INFORMATION for TIROSINT-SOL (levothyroxine sodium) ORAL SOLUTION

WARNING: NOT FOR THE TREATMENT OF OBESITY OR FOR WEIGHT LOSS

Thyroid hormones, including TIROSINT-SOL, either alone or with other therapeutic agents, should not be used for the treatment of obesity or for weight loss.

In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction.

Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects.

Contraindications 

  • Hypersensitivity to glycerol
  • Uncorrected adrenal insufficiency

Warnings and Precautions 

  • Cardiac adverse reactions in the elderly and in patients with underlying cardiovascular disease: Initiate TIROSINT-SOL at less than the full replacement dose because of the increased risk of cardiac adverse reactions, including atrial fibrillation
  • Myxedema coma: Do not use oral thyroid hormone drug products to treat myxedema coma
  • Acute adrenal crisis in patients with concomitant adrenal insufficiency: Treat with replacement glucocorticoids prior to initiation of TIROSINT-SOL treatment
  • Prevention of hyperthyroidism or incomplete treatment of hypothyroidism: Proper dose titration and careful monitoring is critical to prevent the persistence of hypothyroidism or the development of hyperthyroidism
  • Worsening of diabetic control: Therapy in patients with diabetes mellitus may worsen glycemic control and result in increased antidiabetic agent or insulin requirements. Carefully monitor glycemic control after starting, changing, or discontinuing thyroid hormone therapy
  • Decreased bone mineral density associated with thyroid hormone over-replacement: Over-replacement can increase bone reabsorption and decrease bone mineral density. Give the lowest effective dose

Limitations of Use 

  • Not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients
  • Not indicated for treatment of transient hypothyroidism during the recovery phase of subacute thyroiditis

Adverse Reactions

Adverse reactions associated with TIROSINT-SOL are primarily those of hyperthyroidism due to therapeutic overdosage including: arrhythmias, myocardial infarction, dyspnea, muscle spasm, headache, nervousness, irritability, insomnia, tremors, muscle weakness, increased appetite, weight loss, diarrhea, heat intolerance, menstrual irregularities, and skin rash

For more information, visit www.ibsagroup.com/media
*For Full Prescribing Information, visit www.TirosintSOL.com